SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Diplomat Pharmacy, Inc. – (NYSE: DPLO)

BALA CYNWYD, December 18, 2019 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Diplomat Pharmacy, Inc. (“Diplomat” or “the Company”) (NYSE:DPLO) for possible breaches of fiduciary duty and other violations of federal and state law in connection with proposed acquisition of the Company by UnitedHealth Group (NYSE: UNH). Under the terms of the agreement, Diplomat shareholders will receive only $4.00 for each share of Diplomat common stock owned.

The investigation concerns whether the Diplomat Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether UnitedHealth is underpaying for the Company. For example, the deal consideration is significantly below the Company’s 52-week high of $14.53 and, the last trading day before the deal was announced, Diplomat stock closed at $5.81 a share.

If you own shares of Diplomat stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting or calling toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.